Literature DB >> 21631424

Application of nanomedicine in cardiovascular diseases and stroke.

Kye S Kim1, Gilson Khang, Dongwon Lee.   

Abstract

Nanomedicine is using nanotechnology in the medical application, which could range from medical use of nanomaterials in drug delivery and bio-imaging to development of nano-scale devices and sensors for diagnosis and therapy. Nanomedicine could also include methods to evaluate nanomaterials solely to ensure safe use through careful monitoring for potential toxicity. In this review, we will outline some of the potential uses of nanotechnology in different fields of medicine with special emphasis on cardiovascular diseases and stroke, based on pathophysiologic basis. We will also review some of the known nanomaterials that are already being utilized in diagnosis and treatment, commonly the FDA approved nanomaterials and others that have demonstrated to be promising in clinical applications.Finally, we will discuss the potential limitations of using nanotechnology in medical applications. Since nanomedicine is now emerging and still in development, this review is not intended as a comprehensive or conclusive overview of nanomedicine. Instead, we hope to provide examples of what are available currently, and to demonstrate the enormous potentials of nanomedicine in order to meet the unresolved needs and new challenges of medicine.

Entities:  

Mesh:

Year:  2011        PMID: 21631424     DOI: 10.2174/138161211796390967

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  8 in total

Review 1.  Nanocarriers for tracking and treating diseases.

Authors:  Sean Marrache; Rakesh Kumar Pathak; Kasey L Darley; Joshua H Choi; Dhillon Zaver; Nagesh Kolishetti; Shanta Dhar
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

Review 2.  Targeting cell adhesion molecules with nanoparticles using in vivo and flow-based in vitro models of atherosclerosis.

Authors:  Khosrow Khodabandehlou; Jacqueline J Masehi-Lano; Christopher Poon; Jonathan Wang; Eun Ji Chung
Journal:  Exp Biol Med (Maywood)       Date:  2017-01-01

Review 3.  Reactive oxygen species-activated nanomaterials as theranostic agents.

Authors:  Kye S Kim; Dongwon Lee; Chul Gyu Song; Peter M Kang
Journal:  Nanomedicine (Lond)       Date:  2015-09-02       Impact factor: 5.307

Review 4.  Antioxidant-based therapies for angiotensin II-associated cardiovascular diseases.

Authors:  Erin G Rosenbaugh; Krupa K Savalia; Devika S Manickam; Matthew C Zimmerman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-04-03       Impact factor: 3.619

5.  Hydrogen Peroxide-Responsive Nanoparticle Reduces Myocardial Ischemia/Reperfusion Injury.

Authors:  Soochan Bae; Minhyung Park; Changsun Kang; Serkan Dilmen; Tae Hi Kang; Dong Goo Kang; Qingen Ke; Seung Uk Lee; Dongwon Lee; Peter M Kang
Journal:  J Am Heart Assoc       Date:  2016-11-14       Impact factor: 5.501

Review 6.  The Role of Nanomaterials in Stroke Treatment: Targeting Oxidative Stress.

Authors:  Guini Song; Min Zhao; Hanmin Chen; Cameron Lenahan; Xiangyue Zhou; Yibo Ou; Yue He
Journal:  Oxid Med Cell Longev       Date:  2021-03-17       Impact factor: 6.543

7.  H2O2-responsive molecularly engineered polymer nanoparticles as ischemia/reperfusion-targeted nanotherapeutic agents.

Authors:  Dongwon Lee; Soochan Bae; Donghyun Hong; Hyungsuk Lim; Joo Heung Yoon; On Hwang; Seunggyu Park; Qingen Ke; Gilson Khang; Peter M Kang
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

Review 8.  Nanoparticle-Mediated Drug Delivery for the Treatment of Cardiovascular Diseases.

Authors:  Rajasekharreddy Pala; V T Anju; Madhu Dyavaiah; Siddhardha Busi; Surya M Nauli
Journal:  Int J Nanomedicine       Date:  2020-05-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.